+ All Categories
Home > Documents > RADIOFARMASI3

RADIOFARMASI3

Date post: 07-Jul-2018
Category:
Upload: ayu-apriliani
View: 216 times
Download: 0 times
Share this document with a friend

of 324

Transcript
  • 8/18/2019 RADIOFARMASI3

    1/324

    RADIOFARMASI

    Dosen:A. Mutalib MSc, PhD

  • 8/18/2019 RADIOFARMASI3

    2/324

    Penggunaan prinsip dan cara-cara farmasi danradiokimia untuk membuat obat yangmengandung atom radioaktif  (radiofarmaka) bagi keperluan diagnosa dan penembuhan(terapi) penakit ang diidap oleh pasien.

    !adiopharmac

     "uclear Pharmac 

    !adiofarmaka (radiopharmaceuticals):

    Sena#a kimia atau obat, dimana salah satu atom penusun struktur kimiaobat tersebut adalah nuklida radioaktif, digunakan untuk keperluandiagnosa atau penembuhan (terapi) suatu penakit dan diberikan ke pasien bisa secara oral, parenteral, atau inhalasi oleh spesialis kedokteran nuklir.

    $edokteran "uclear (nuclear medicine):%idang keahlian (specialist) kedokteran ang berhubungan dengan penggunaan dan pemberiaan radiofarmaka kepada pasien untuktu&uan diagnosa dan terapi suatu penakit.

  • 8/18/2019 RADIOFARMASI3

    3/324

    γ γ γ γ  

    γ γ γ γ  

    'amma amera

    Perbedaan !adiologi dan $edokteran "uklir 

  • 8/18/2019 RADIOFARMASI3

    4/324

    enis radiasi atom radioaktif ang dimanfaatkan dalamkedokteran nuklir 

    !adiofarmaka diformulasikan dalam berbagai#u&ud kimia dan fisika untuk mengarahkan(targeted) keradioaktifan ke bagian-bagiantertentu dari tubuh

  • 8/18/2019 RADIOFARMASI3

    5/324

    • !adiasi-γ ang dipancarkan dari radiofarmaka diagnosadengan mudah akan keluar dari tubuh sehinggamemungkinkan deteksi dan pengukuran dilakukan diluar tubuh (eksternal). Pola distribusi radiasi dalam suatu organ terhadap #aktu

    memungkinkan dokter spesialis kedokteran nuklir melakukane*aluasi morfologi dan fungsi sistem.

    • !adiofarmaka terapi memancarkan radiasi dalam bentuk partikel bermuatan, misalna β atau α, angmendepositkan energi kedalam organ ang sedangdisembuhkan dari penakit.

  • 8/18/2019 RADIOFARMASI3

    6/324

    " +

    P

    Sc

    Sr !b

    l

    n

    'a

    Au Pb %i

    u

    Pd!hc

    !e

    Sm D /o 0u

     positron beta gamma alfa

    1

    b

    At

    Unsur kimia yang atom radioaktifnya untuk

    diagnosa dan terapi

  • 8/18/2019 RADIOFARMASI3

    7/324

    Prosedur penggunaan radiofarmaka di dalamkedokteran nuklir dapat dibagi dalam tiga kategori:

    2. Prosedur imaging atau pencitraan

    3. $a&ian fungsi in *i*o

    4. Prosedur terapi

    diagnosa

  • 8/18/2019 RADIOFARMASI3

    8/324

    Evolving Paradigm in Medicine

    Imaging

    Anatomy Biochemical

    Therapy

    Systemic Targeted

  • 8/18/2019 RADIOFARMASI3

    9/324

    maging Modalities Anatomy Physiology Metabolism Molecular 

    CTUS

    MRI

    MRS

    fMRI

    Nuclear SPECT/PET

    Optical Imaging

    Nanosensor 

  • 8/18/2019 RADIOFARMASI3

    10/324

     Radiopharmaceutical(Biological activemolecule labeled witha gamma-emittingradioisotopes5)

    Nuclear Medical Imaging System

    11C  1! 

    1"O  1#

    F $$m%c  111I

    &'

    (a 

    1)I

    *

    (6mitted !adiation: penetrate the bod)

    *+%, S*+C% 

    (67ternal Detectingsstem of !adiation)

    PET, SPECT

    Computer System 

    Image of  radioactivitydistribution

    !on,in-asi-e -i.uali.ation/iochemical and physiologfunctions in -i-o0

    (analsis of information ofradiacti*it distribution)

    Distribute totarget tissues

    !adionuclide emits radiation

  • 8/18/2019 RADIOFARMASI3

    11/324

    Prosedur imaging memberikan informasi diagnosaatas dasar pola distribusi keradioaktifan di dalamtubuh. $a&ian dinamik imaging memberikan informasifungsional melalui pengukuran la&u akumulasi dan la&

    ekskresi radiofarmaka.

    $a&ian statik imaging memberikan informasi morfolo berkenaan dengan ukuran, bentuk, dan letak organ ataadana lesi ang menempati ruang, dan dalam beberakasus mengenai fungsi relatif.

    Pola distribusi radiofarmaka dalam suatu organ ber*ariasi dantergantung organ ang diamati dan ada atau tidak adana penakit

  • 8/18/2019 RADIOFARMASI3

    12/324

    %iga enis pengamatan melalui imaging

    2pencitraan34A. itra (image) dalam bentuk 8hot spots9 atas dasar

    terkonsentrasinaterakumulasina keradioaktifan secaramerata (uniform) di organ ang sehat atau normal. Sedangkan

    8cold spots9 dinatakan sebagai lesi (lesion) atau &aringan

     berpenakit ang menolak atau mengeluarkan radiofarmaka

    tersebut.Misalna, pada penatahan (scanning) li*er dengan partikel koloid

     bertanda radioaktif ; setelah partikel koloid tersebut diin&eksikan, partike

     berakumulasi pada sel-sel phagoctosis ang terdapat di li*er. %ila tumor

    atau lesi berada di dalam li*er, maka sel-sel ang melokalisasi koloid

    radioaktif akan digantikanna, sehingga tampak sebagai 8cold spot9.

  • 8/18/2019 RADIOFARMASI3

    13/324

    iga &enis pengamatan melalui imaging (pencitraan):

    %. itra (image) dalam bentuk 8hot spots9 ditimbulkan oleh

    terakumulasina keradioaktifan secara merata (uniform) di dalorgan berpenakit atau lesion, sedangkan &aringan ang sehat

    atau normal menolak atau mengeluarkan radiofarmaka tersebu

    sehingga citra muncul sebagai 8cold spots9. Misalna, penatahan otak dengan menggunakan

    radiofarmaka ang ditolak oleh

  • 8/18/2019 RADIOFARMASI3

    14/324

    iga &enis pengamatan melalui imaging (pencitraan):

    . +rgan normal bisa mengakumulasikan radiofarmaka, tetapi

     &aringan berpenakit mampu mengakumulasikanna baik padatingkat ang lebih tinggi lagi bila fungsi organ berlebihan atau

    meningkat, maupun pada tingkat ang lebih rendah dari pada

    organ normal apabila fungsi organ menurun. Misalna, dalam pencitraan kelen&ar throid (throid gland) denganmenggunakan iodium radioaktif. $elen&ar throid dengan mudah

    mengakumulasikan radiofarmaka iodium-242 melalui fungsi normal, teta

    kelen&ar ang sakit dengan &aringan throid ang hperfunction atauhpofunction akan menun&ukkan konsentrasi radioiodium-242 ang

    meningkat atau menurun. 

  • 8/18/2019 RADIOFARMASI3

    15/324

    ardiac maging

    • ardiac function

     "ormal function Decrease function

  • 8/18/2019 RADIOFARMASI3

    16/324

    $idne Scan

    • !enal transplantation

     "ormal!e&ection

  • 8/18/2019 RADIOFARMASI3

    17/324

    Modalitas ang digunakan $edokteran "uklir 

    M d lit di k $ d kt " kli

  • 8/18/2019 RADIOFARMASI3

    18/324

    ollimator 

    SP6SP6P6

    P6

    Modalitas ang digunakan $edokteran "uklir 

  • 8/18/2019 RADIOFARMASI3

    19/324

    PET/CT

    A hbrid fusion of P6 and .

    he P6 gi*e a fusion of anatomic and functional data.

  • 8/18/2019 RADIOFARMASI3

    20/324

    A hybrid usion o PET and CT!

    Functional Image Anatomical Image   “Fusion”Image

    "usion Image

    (PT! (CT! (PT"CT! PET/CT bisa mengatasi resolusi ruang (spatial resolution) yang rendah dari PET imaging.

    Sehingga akumulasi keradioaktifan dapat dideteksi dari lesi yang sangat kecil secara anatomi

  • 8/18/2019 RADIOFARMASI3

    21/324

    l h 1 i =i

  • 8/18/2019 RADIOFARMASI3

    22/324

    elaah 1ungsi n =i*o

    Mengukur fungsi suatu organ atau sstem didasarkan

    atas absorpsi, pengenceran (dilution), pemekatan, atauekskresi keradioaktifan setelah pemberian radiofarmaka.

    ara ini tidak memerlukan pencitraan, tetapi analisis dan interpretasididasarkan atas pencacahan keradioaktifan ang muncul baik secara

    langsung dari organ-organ ang berada di dalam tubuh atau dari cuplikandarah atau urin ang dicacah secara in *itro.

    !adiofarmaka sendiri harus tidak mempengaruhi, dalam cara apapun,

    fungsi sistim organ ang sedang diukur.

    l h 1 i =i (b b h)

  • 8/18/2019 RADIOFARMASI3

    23/324

    elaah 1ungsi n =i*o (beberapa contoh)• elaah uptake iodium radioaktif untuk mengka&i fungsi kelen&ar

    throid sebagaimana ditentukan dengan pengukuran eksternal

     prosentase dosis radioidium ang diambil oleh kelen&ar *s.#aktu.

    • Penentuan *olum darah keseluruhan dengan mengukur pengenceran dari se&umlah tertentu sel darah merah bertanda>2r ang diin&eksikan secara intra*ena dalam suatu *olum selmerah.

    • Pengka&ian tak langsung absorpsi *itamin %23 dari

    gastrointestinal tract dengan mengukur fraksi *itamin %23 bertanda >?o ang diberikan secara oral ang diekskresikan didalam urin dalam perioda #aktu tertentu (Schilling test).

  • 8/18/2019 RADIOFARMASI3

    24/324

    Prosedur erapi

    Paliati*eurati*e:

    lassic therap

    !adioimmunotherap (!)

    Peptide !eceptor !adionuclidic herap (P!!)

  • 8/18/2019 RADIOFARMASI3

    25/324

    Internal Radiation Therapy 5ith 11I,MI6(

    ( beore Treatment) ( ater

    Treatment)

    The %efuse accumulation of ra%ioacti$ity

    +as obser$e% in the lung area-

    No accumulation of ra%ioacti$ity +as

    obser$e% in the lung area-

  • 8/18/2019 RADIOFARMASI3

    26/324

    atom tersusun dari inti atom dan satu atau lebih

    elektron bergerak mengitari inti atom di dalam orbitenergi ang berbeda

    inti atom (nucleus) tersusun terutama dari proton danneutron  disebut nukleon

     &mlh elektron suatu unsur @ &mlh proton

    Struktur Atom

    $  0

    M

    "

    %eori 6ohr4

    Atom merupakan partikel terkecil dari suatu unsurang memiliki sifat-sifat unsur 

    Struktur nti

  • 8/18/2019 RADIOFARMASI3

    27/324

    Struktur nti

    @ nomor atom @ &umlah proton di dalam

    inti atom

    %erat proton @ 2.B?3C 7 2-3? kg

    2.?3? amu%erat neutron @ 2.B?C? 7 2-3? kg

    2.EBB amu

    A @ nomor massa @ &umlah nukleon di dalaminti atom

     @ F "

    nti atom:

    neutron proton nukleon

    Misal: inti alumunium stabilmemiliki &umlah proton 24 () dan &umlah neutron 2C ("), maka nomor

    massa (A) alumunium adalah 3? dannomor atomna () adalah 24

    umlah elektron atom netral @ &umlah proton ang berada di dalam inti atom

    tsb.

    erminologi

  • 8/18/2019 RADIOFARMASI3

    28/324

    erminologi

    %ila nuklidana tidak stabil atau radioaktif maka sering disebut sebagairadionuklida.

     "uklida adalah sebutan umum untuk setiap inti atom, baik inti g stabilmaupun tidak stabil atau radioaktif, ang dicirikan dengan nomor atom ()

    dan nomor massa (A) tertentu:>3Misal: Mn3>G

    A

     "uklida-nuklida ang memiliki nomor atom atau &umlah proton ang samadisebut isotop dan nuklida-nuklida tersebut memiliki sifat kimia ang samakarena memiliki &umlah elektron ang sama. sotop ang tidak stabil atauradioaktif disebut radioisotop.

    Misalna: , , dan+2>E +2BE +2?E +2EE

    erminologi

  • 8/18/2019 RADIOFARMASI3

    29/324

    erminologi "uklida-nuklida ang memiliki &umlah neutron ang sama tetapi memiikinomor atom ang berbeda disebut isoton.

    Misalna: , , dan masing-masing memiliki 44 neutron>H1e3B

    Bo

    3?

    B2 "i

    3E

    BCu

    3H

     "uklida-nuklida dengan &umlah nukleon ang sama atau dengan nomor mass(A) ang sama, tetapi &umlah proton dan neutron berbeda atau nomor atom berbeda disebut isobar.

    Misalna: , , dan masing-masing memilikiB?u3H B?n4 B?'a42 B?'e43nomor massa ang sama B?

     "uklida-nuklida ang memiliki &umlah proton dan neutron ang sama tetapimemiiki tingkat energi dan spin ang berbeda disebut isomer.

    Misalna: dan merupakan isomer dari nuklida ang samaHHmcC4 HHcC4

    Model nti

  • 8/18/2019 RADIOFARMASI3

    30/324

    Model ntiModel tetesan cairan:

    inti dianggap berbentuk 8spheric9 dan tersusun dari nukleon angdikemas berdekatan

     partikel ang dipancarkan dari dalam inti mirip seperti penguapanmolekul-molekul dari suatu tetesan cairan

    Dengan teori ini dapat di&elaskan kerapatan inti, energi ikat, energetik partikel ang dipancarkan inti, dan pembelahan inti berat

    nukleon di dalam inti atom ditata di dalam kulit energi seperti konfigurasi

    elektron ang ditata di dalam kulit atom berdasarkan teori %ohr. nti angmengandung 3, E, 3, >, E3, atau 23B proton atau neutron merupakan intisangat stabil. umlah nukleon tersebut disebut bilangan magik.

    Model kulit:

    $estabilan nti

  • 8/18/2019 RADIOFARMASI3

    31/324

    $estabilan nti

    nti stabil umumna &umlah proton genap dan neutron genap

    nti kurang stabil &umlah proton gan&il dan &umlah neutron gan&ilAngka-banding (ratio) &umlah neutron terhadap &umlah proton:

    Salah satu indeks pendekatan utk kestabilan nuklida "

    @ 2 untuk nuklida stabil dengan nomor atom rendah, misalna

    , dan +2BE23

    B  "2C

    ?

    Diatas @3, nilai " akan semakin tinggi dengan semakinnaikna nomor atom dari inti atom. Misalna " @ 2.C untukdan 2.>C untuk  Pb3EE3

    23?>4

  • 8/18/2019 RADIOFARMASI3

    32/324

    np too large beta deca

    G

    np too small

     positron deca or electroncapture

     "umbers of protons 3 C B E

    3

    C

    B

    E

    2

    23

       "  u  m   b  e  r  s

      o   f  n  e  u   t  r  o  n  s

    %elt of stabilit

     "eutronsProtons

    %ila suatu inti memiliki nilai "  berbeda dengan nilai " intistabil, maka inti atom tersebut

    merupakan inti ang tidak stabildan selan&utna inti akanmengalami peluruhan (deca)dengan memancarkan partikel β atau melalui tangkapan elektron

    $estabilan nti

  • 8/18/2019 RADIOFARMASI3

    33/324

    $estabilan ntiMassa inti (M) selalu lebih kecil dari pada massa gabungannukleon (A) ang berada di dalam inti tersebut

    Defek massa @ M - ADefek massa digunakan sebagai energi untuk mengikat semuanukleon ang ada di dalam inti, dan energi ini disebut energi ikatatau binding energ

    $estabilan suatu nuklida dipengaruhi oleh tatanan struktural nukleondan energi ikat nukleon

    $riteria kestabilan:  "ilai " nuklida stabil

    radionuklida meluruh untuk mencapai nilai " nuklida stabil sedekat mungkin

    Peluruhan radioaktif

  • 8/18/2019 RADIOFARMASI3

    34/324

    Peluruhan radioaktif 

    nti tidak stabil berupaa mencapai keadaan stabil dengan cara pembelahan (fission) spontan, memancarkan partikel α, partikel

    β atau foton-γ , atau tangkapan elektron (electron capture)

    Peluruhan radioaktif dengan memancarkan partikel atau tangkapanelektron akan menebabkan perubahan nomor atom; peluruhan dengan

    memancarkan foton tidak mengalami perubahan.

    !adiasi  pemancaran dan pen&alaran (propagation) energimelalui ruang, dalam bentuk partikel atau gelombang

    elektromagnetik 

    Peluruhan radioaktif

  • 8/18/2019 RADIOFARMASI3

    35/324

    Peluruhan radioaktif 

    $arena itu radionuklida dapat meluruh (deca) melalui salahsatu atau kombinasi dari lima proses berikut:

    Dalam semua proses peluruhan berlaku kekekalan energi,massa, dan muatan radionuklida.

     peluruhan α, peluruhan β-, peluruhan βF, tangkapan elektronatau transisi isomerik 

    Peluruhan α

  • 8/18/2019 RADIOFARMASI3

    36/324

    Peluruhan α

    er&adi terutama untuk radionuklida ang lebih berat dari pada Pb,misalna radon, uranium, neptunium, dst.

    Partikel α merupakan inti helium ang mengandung dua proton dandua neutron ang terikat bersama-sama, /e

    C3

    Dalam peluruhan α, nuklida induk mengalami pengurangan nomor atom,3 satuan, dan pengurangan nomor massa, C satuan.

    ontoh: I34>H3

    h342H F /e

    C3

    ransisi α  bisa diikuti dengan pemancaran sinar γ 

    Partikel α merupakan partikel monoenergetik , dan &angkauanna(range) di dalam materi sangat pendek , aitu dalam orde 2-B cm.

    Peluruhan β−

  • 8/18/2019 RADIOFARMASI3

    37/324

    Peluruhan β

    Peluruhan β− ter&adi bila inti memiliki neutron ang berlebih, 8neutronrich9   " JJ dibandingkan dengan inti stabil

    Dalam peluruhan β− , neutron  secara esensial meluruh men&adi proton, partikel β− dan antineutrino ( ν-)

    n p F β−  F  ν−

    Antineutrino merupakan partikel tanpa massa dan muatan; keberadaannamerupakan persaratan ang diperlukan untuk kekekalan energi

    Partikel β− ang dipancarkan memiliki energi ang ber*ariasi, mulai dari

    sampai energi peluruhan (deca energ). 6nergi peluruhan adalah perbedaanenergi antara nuklida induk dan nuklida anak.

    Peluruhan β−

  • 8/18/2019 RADIOFARMASI3

    38/324

    Peluruhan β

    6nergi ang diba#a antineutrino merupakan selisih energi partikel β− dandeca energ.

    Peluruhan β− bisa diikuti dengan pemancaran sinar γ. Setelah peluruhan nuklida anak bertambah 2 lebih besar dari nuklida induk.

    ontoh: 242

    >4

    Ge242

    >CF β− F  ν−

    1e>H3B

    o>H3? F β

    − F  ν−

    MoHHC3

    cHHmC4 F β

    − F  ν−

     Bremsstrahlung sinar-7 ang ter&adi akibat interaksi antara partikel β− dengan medium sekitarna. $eboleh&adian terbentuknabremsstrahlung makin tinggi dengan semakin tinggi energi partikel β− dan medium

    Skema Peluruhan 242

  • 8/18/2019 RADIOFARMASI3

    39/324

    Skema Peluruhan

    242>4 (E hari) β−

    ?34 ke=

    B4?

    4BC

    E

    Ge242>C (stabil)

    2,BK

    B,HK

    H,CK

    Peluruhan β+ atau positron

  • 8/18/2019 RADIOFARMASI3

    40/324

    Peluruhan β  atau positron

    er&adi bila inti miskin neutron atau kaa proton

    memiliki nilai " L dibandingkan dengan inti stabil

    Setelah pemancaran partikel β+, nuklida anak memiliki L satu satuandari pada nuklida induk. Pemancaran partikel disertai pemancaranneutrino ( ν)

    Pada akhir lintasanna, positron bergabung dengan elektron dan ter&adi anihilasi angdisusul dengan muncul dua foton, masing-masing dengan energi >22 ke=, dalam arah

     berla#anan. 1oton tersebut dinatakan sebagai radiasi anihilasi.

    Pemancaran positron ter&adi apabila perbedaan energi nuklida induk dannuklida anak J 2,3 Me=

    eFe->22 ke=>22 ke=

    Peluruhan β+ atau positron

  • 8/18/2019 RADIOFARMASI3

    41/324

    Peluruhan β  atau positron

    Dalam peluruhan β+, proton berubah men&adi neutron ang disertaidengan pemancaran partikel β+ dan neutrino

     p n F β+  + ν

    ontoh: 12E

    HF β+ F  ν

    uBC3H

     "iBC3E F β

    + F  ν

    1e>33B

    Mn>33> F β

    + F  ν

    +2E

    E

    angkapan elektron (6)

  • 8/18/2019 RADIOFARMASI3

    42/324

    g p ( )

    Alternati*e dari peluruhan β+

    Mentransformasikan proton men&adi neutron disertai dengan pemancaran neutrino

    Penangkapan elektron dari kulit atom bagian dalam(elektron kulit $) $ capture

    Diikuti pengisian elektron dari kulit luar,misalna kulit 0 atau M

    Sinar 7

    $eboleh-&adian tangkapan elektron bertambah dengan semakin besar nomoatom, karena kulit elektron semakin mendekat inti

    ransisi isomerik ()

  • 8/18/2019 RADIOFARMASI3

    43/324

    nti atom dapat berada dalam beberapa keadaan tereksitasi diatas keadaandasar. Semua keadaan tereksitasi dinatakan sebagai keadaan isomerikang bisa meluruh ke keadaan dasar dalam masa beberapa piko-detik . %ila

    keadaan isomerik berumur lama maka dinatakan sebagai keadaanmetastabil.

    c (B,3 &am)HHmC4

    c (3,23 7 2> tahun)HHC4

    2C3 ke=

    2C ke=

    sinar-γ 

    Proses kon*ersi internal

  • 8/18/2019 RADIOFARMASI3

    44/324

    e-

    sinar-7

    sinar-γ 

    6lektron kon*ersi

    6lektron kon*ersi memiliki energi:

    6c@ 6γ - 6%6γ  dan 6% masing-masingadalah energi sinar-γ  danenergi ikat elektron angterlempar

    Proses kon*ersi internal merupakan alternatif dari proses transisi isomerikPerbandingan &umlah elektron kon*ersi dan &umlah foton ang teramatidinatakan sebagai koefisien kon*ersi

    Makin besar nilai α maka makin kecil &umlah foton ang teramati.$eboleh&adian kon*ersi internal lebih tinggi untuk foton energi rendah.

    γ 

    α 

      

    e  =

    Persamaan peluruhan keradioaktifan

  • 8/18/2019 RADIOFARMASI3

    45/324

    p

    Peluruhan radionuklida merupakan proses acak (random) artina kita tidak dapatmenatakan atom ang mana dari sekelompok atom ang akan meluruh pada #aktu ang

    spesifik, tetapi kita hana bisa menatakan &umlah rata-rata radionuklida ang akanmengalami disintegrasi selama perioda #aktu tertentu.

    umlah disintegrasi per satuan #aktu, -d/dt! suatu radionuklida pada setiap saat adalahsebanding dengan &umlah total radionuklida ang berada pada saat tersebut.

    !adionuklida nuklida tidak stabilm e l u r u 

    h   -

    memancarkan partikel- memancarkan foton- tangkapan elektron

      dt 

    d  λ =−

    Persamaan peluruhan keradioaktifan

  • 8/18/2019 RADIOFARMASI3

    46/324

    p

       adalah &umlah radionuklida dan λ adalah tetapan peluruhan angdidefenisikan sebagai keboleh&adian disintegrasi per satuan #aktu untuksuatu radionuklida tunggal

    (2)

    Persamaan (2) bila diintegralkan:

    (3)

      &umlah inti pada #aktu t dan bila t " maka &umlah inti  , sehingga

      dt 

    d λ =−

    ∫ ∫ =− dt   

    d λ 

    integrasitetapanln +=− t      λ 

    integrasitetapanln =−   

    Persamaan peluruhan keradioaktifanP (3) di k b li

  • 8/18/2019 RADIOFARMASI3

    47/324

    Persamaan (3) disusun kembali:

    (4)Dalam proses peluruhan &umlah " inti akan berkurang secara eksponensialdengan semakin lamana #aktuaktu ang diperlukan agar " berubah setengahna dinatakan sebagai#aktu paruh, t #/$

    (C)

    lnln      −=−   λ t 

         λ t =−

    ln

    e  

         λ t −=

    e      λ t −

    =

    32

    32

    e  

         λ t −==λ λ 

    BH4.)3(ln32

    ==t 

    Persamaan peluruhan keradioaktifan

  • 8/18/2019 RADIOFARMASI3

    48/324

    %esaran lain ang berkaitan dengan radionuklida adalah umur rata-rata (meanlife), τ, ang dinatakan dengan persamaan berikut:

    (>)

    $eradioaktifan (radioacti*it) suatu radionuklida atau secara sederhanadinatakan sebagai keaktifan atau aktifitas (acti*it) merupakan besaran ansebanding dengan λ   , maka:

    Sehingga radioaktifitas atau aktifitas suatu radionuklida pada #aktu t! adala

    (B)

    3232 CC.2BH4.2 t t  === λ τ 

      dt 

    d  %   λ =−=

    t  e % %  λ t −=

    A

    2t                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          )                                                                                                                                                                                                                                                                                                                   

  • 8/18/2019 RADIOFARMASI3

    49/324

    A3

    AC

    2 3 4 C > Bime (hal*e-li*es)

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       c                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           t                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   i

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         *                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           i                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        t                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

    3>

    >

    2

    2 3 4 C B ?

    ime (half-li*es)

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            l                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       o                   

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           g                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       c                   

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            t                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   i                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           i                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         t          

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     (                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            a             

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           r                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         b                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            i                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        t                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 r                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       a             

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           r                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               u                   

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         i                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        t          

    he half-life of a radionuclide can be determined e7perimentall b measuring

    acti*it of a sample o*er time, assuming that the half-life is reasonabl short.!adionuclides #ith *er short or *er long half-li*es reNuire special techniNues

    t 1/2

    Satuan radioaktifitas

  • 8/18/2019 RADIOFARMASI3

    50/324

    Satuan radioaktifitas pada mulana didasarkan atas la&u peluruhan 2 gradium dan dinatakan dalam curie (i).

    Sekarang besaran atau kuantitas setiap nuklida radioaktif dinatakan dalam &umlah disintegrasi per detik (dps atau dis s-2)

    2 dps @ 2 dis s-2 @ 2 becNuerel @ 2 %N dalam satuan S

    2 %N @ 2 7 2-4 k%N (kilobecNuerel) @ 2 7 2-B M%N (megabecNuerel)

    2 i @ 4.? 7 22 dps @ 4.? 7 22 %N@ 3.33 7 223 (disintegrasi per menit )

    2 milicurie (mi) @ 4.? 7 2? dps @ 4.? 7 2? %N

      @ 3.33 7 2H

     dpm2 mikrocurie (mi) @ 4.? 7 2C dps @ 4.? 7 2C %N  @ 3.33 7 2B dpm

    Satuan radioaktifitas

  • 8/18/2019 RADIOFARMASI3

    51/324

    $onsentrasi keradioaktifan suatu radionuklida dinatakan sebagai besarnakeaktifan atau keradioaktifan radionuklida tersebut persatuan *olum.

    Misalna µiml, miml, %Nml, k%Nml, dst. 

    $eaktifan &enis (specific acti*it) adalah besaran keaktifan radionuklidaang dinatakan sebagai besarna keradioaktifan per satuan massa .

    Misalna µig, mig, %Ng, k%Nmol, dst.

    A 2 mg 242-labeled albumin contains 2> mi 242 radioacti*it. ts specacti*it #ould be 2.> mimg.

    he specific acti*it of a carrier-free radionuclide sample is related to half-life of the radionuclide: the shorter the half-life, the higher the specacti*it

    ontoh perhitungan:/itung &umlah total atom dan massa total 242 ang berada di

  • 8/18/2019 RADIOFARMASI3

    52/324

    /itung &umlah total atom dan massa total 4 ang berada didalam > mi 242 dengan #aktu paruh t23 @ E hari

    λ untuk242

    Massa total 242 di dalam > mi:

    dps274.?7> ?= %

    atom27E>.2s272dps27E>.2

     "

    %A2C

    2-B-

    E

    A*ogadro

    ===

    ==

    λ 

    λ λ 

     %  

    &    %

    A*ogadro "7

    %A7

    λ 

     %&  =

    ngC.4g274.C27B.37)s(272

    (gatom)2427(dps)27E>.2 H-342-B-

    E

    ===

    2-B-

    s27.2sB7B73C7E

    BH4.

    ==

    ontoh perhitungan:Pada &am 22. pagi di suatu hari tertentu hasil pengukuran keradioaktifan HHm

  • 8/18/2019 RADIOFARMASI3

    53/324

    ada &a . pag d sua u a e e u as pe gu u a e ad oa amenun&ukkan H mi. %erapa keradioaktifan pada &am E. pagi dan pada &amC. sore di hari ang samaO (t23 untuk HHmc adalah B &am)

    $eradioaktifan pada &am E. pagi menun&ukkan keradioaktifan lebih a#a &am dari keradioaktifan hasil pengukuran pada &am 22. pagi, maka:

    Akti*itas pada &am C. sore:

    2- &am22>>. &amBBH4. ==λ 

    mi?.237(mi)H

    miH(&am)47)(&am22>>.

    E &am pd

    (&am)47)(&am22>>.22 &am pd

    2-

    2-

    ===

    ====

    e % %

    e % % %e % %

     t 

    λ 

    mi>.>7(mi)H

    miH(&am)>7)(&am22>>.

    soreC &am pd

    22 &am pd

    2-

    ====

    ==−−

    ee % % %

     % %

    λ t 

    Persamaan umum peluruhanika radion klida A mel r h men&adi radion klida % dan selan& tn a

  • 8/18/2019 RADIOFARMASI3

    54/324

    ika radionuklida A meluruh men&adi radionuklida %, dan selan&utnaradionuklida % meluruh men&adi radionuklida lain , A % ,maka la&u pertumbuhan % dinatakan sbb:

    %ila persamaan diatas diintegrasikan dan dinatakan dalam akti*itasradionuklida %:

    %ila λ  B J λ  %,, dengan kata lain (t23)% L (t23)A, maka dapat diabaikan dibandingkan

    dengan dan bila t cukup besar, maka akti*itas radionuklida %:

    hubungan ini disebutkesetimbangan transient

    (?)

    (E)

    (H)

     B B % %

     B     dt 

    d λ λ  −=

    t t t 

     % B

     % % B

     B B

     B B % eee      λ λ λ 

    λ λ λ λ λ  −−− −−−

    == o%

    % A)(A

     % B

     Bt 

     % B

     % % B  %e  

    λ λ 

    λ 

    λ λ 

    λ λ    λ 

    −=

    −= −

    tA

    t%

    A)(A

    t  Be  λ −

    t  %e  λ −

    Persamaan umum peluruhan$ i b i b l k bil ( ) d ( ) b b d d

  • 8/18/2019 RADIOFARMASI3

    55/324

    $esetimbangan transient berlaku apabila (t23)A dan (t23)% berbeda denganfaktor 2->. Misalna HHMo (t23 @ B? &am) meluruh men&adi HHmc (t23 @ B &am).

    ontoh soal: ttrium-E? (t23 @ E &am) meluruh men&adi E?mSr (t23 @ 3.>4 &am). Akti*itas cuplikan murni E? dikalibrasi pada tengah hari di hari!abu dan diperoleh akti*itas sebesar 4 mi. /itung akti*itas E?mSr pada &am B sore di hari !abu dan hitung &uga akti*itas E?mSr pada &am B sore di

    hari $amis.λΑ=0.693/80 &am @ .E? &am-2; λΒ=0.693/2.83 &am @ .3CCH &am-2

    t@ B &am dari tengah hari sd &am B sore

    4BE.2E?.3CCH.

    3CCH. =−

    =−

     % B

     B

    λ λ 

    λ 

    342.

    HCH2. &amB7)(&am3CCH.

     &amB7)(&amE?.

    2-

    -2

    ====

    −−

    −−

    ee

    ee

     B

     %

    λ 

    λ 

    mi4A A =

    ontoh soal:

  • 8/18/2019 RADIOFARMASI3

    56/324

    Akti*itas E?mSr pada &am B sore di hari !abu adalah:

    Akti*itas E?mSr pada &am B sore di hari $amis adalah:

     t @ 4 &am

    Dengan menggunakan persamaan (H), maka akti*itas E?mSr :

    mi334.B.342)-(.HCH27(mi)474BE.2A t% ==

    mi342.27(mi)4A (&am)47) &am(E?.tA-2

    == −e

    mi34H.B(mi)342.272.4BEA t% ==

    Persamaan umum peluruhan

  • 8/18/2019 RADIOFARMASI3

    57/324

    Apabila λ  B '' λ  % , a